Today, the American Gastroenterological Association (AGA) published a white paper on the future of inflammatory bowel disease (IBD) care in the United States.
Exclusive: Ultragenyx secures first funds for Alzheimer’s gene therapy spinout
Rare disease specialist Ultragenyx reeled in a $14 million seed round for its Alzheimer’s gene therapy spinout Amlogenyx, the company exclusively told Endpoints News. …